BIO GREEN MED SOLUTION INC (BGMS)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
$0.90-1.96%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
QuarterlyIQ Insights · BGMS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.0 | 0.8 | 1.9 | 1.7 | 1.1 | 0.1 | 0.7 |
| Total Revenues | — | 0.0 | — | — | — | — | — | — | — | 0.0 | 0.8 | 1.9 | 1.7 | 1.1 | 0.1 | 0.7 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | 5.4 | 6.7 | 7.4 | 7.5 | 5.9 | 5.0 | 5.4 | 5.3 | 5.5 | 5.7 | 5.9 | 7.8 | 8.6 | 6.5 |
| R&D Expenses | — | 0.8 | 6.7 | 19.2 | 20.3 | 14.9 | 4.8 | 4.7 | 4.3 | 4.2 | 9.5 | 12.4 | 18.3 | 11.3 | 6.6 | 9.2 |
| Operating Income | (3.6) | (8.4) | (12.0) | (25.5) | (27.7) | (22.4) | (10.6) | (9.7) | (9.5) | (9.5) | (14.2) | (16.2) | (22.4) | (18.0) | (15.1) | (15.7) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| Interest & Investment Income | — | — | 0.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0.2 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | (0.0) |
| Other Non-Operating Income / Expenses | 5.5 | 5.4 | 0.0 | (0.1) | 1.7 | 0.2 | 1.0 | 0.6 | 0.9 | 1.0 | 0.4 | (0.3) | (0.2) | 6.1 | (0.0) | 0.6 |
| EBT, Incl. Unusual Items | 1.9 | (3.0) | (12.0) | (25.6) | (25.9) | (22.2) | (9.7) | (9.1) | (8.6) | (8.5) | (13.8) | (16.5) | (22.6) | (11.9) | (15.1) | (15.2) |
| Income Tax Expense | — | 0.0 | (0.8) | (3.0) | (4.7) | (3.7) | (1.2) | (1.3) | (1.3) | (1.0) | (2.0) | (2.1) | (3.2) | (1.7) | (1.4) | (0.6) |
| Net Income | ||||||||||||||||
| Net Income | (2.2) | (3.0) | (11.2) | 22.6 | (21.2) | (18.5) | (8.4) | (7.8) | (7.3) | (7.5) | (11.8) | (14.3) | (19.4) | (10.2) | (13.2) | (15.2) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.39) | (6.45) | (2.09) | — | (1.90) | (2.09) | (3.42) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.39) | (6.45) | (2.09) | — | (27.24) | (2.09) | (3.42) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 5.6 | 2.2 | 5.4 | 3.5 | 11.3 | 8.9 | 3.6 | — | — | — | — | — | — | 15.2 | 8.3 | 7.2 |
| Diluted Weighted Avg Shares | 5.6 | 2.2 | 5.4 | 3.5 | 11.3 | 8.9 | 3.6 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | — | — | (10.6) | (9.7) | (9.5) | 22.5 | (14.1) | (16.0) | (22.2) | (17.8) | (15.0) | (15.5) |
| EBIT | (3.6) | (8.4) | (12.0) | (25.5) | (27.7) | (22.4) | (10.6) | (9.7) | (9.5) | (9.5) | (14.2) | (16.2) | (22.4) | (18.0) | (15.1) | (15.7) |
| Effective Tax Rate | — | — | — | 11.7% | 18.2% | 16.8% | 12.8% | 14.2% | 15.5% | 11.7% | 14.4% | 13.0% | 14.3% | 14.1% | 8.9% | 3.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.